PCL Inc., possessing the original technology on multiplex immunodiagnosis, specializes in the in vitro diagnosis medical device.
​Since its establishment in 2008, we succeeded in commercializing the world's first high-risk viral blood screening multiplex immunodiagnostic product based on our original technology.
Furthermore, our company succeeded in commercializing highest class and large in vitro diagnostic medical device equipments in the IVD sector for the first time in Korea, becoming an in vitro diagnostic company that leads the existing single immunodiagnostic market into a multiplex immunodiagnostic market.